These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24659885)

  • 1. Current testing strategies for hepatitis C virus infection in blood donors and the way forward.
    Marwaha N; Sachdev S
    World J Gastroenterol; 2014 Mar; 20(11):2948-54. PubMed ID: 24659885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
    Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
    Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.
    Tuke PW; Grant PR; Waite J; Kitchen AD; Eglin RP; Tedder RS
    Transfusion; 2008 Apr; 48(4):594-600. PubMed ID: 18194388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply.
    Candotti D; Sauvage V; Cappy P; Boullahi MA; Bizimana P; Mbensa GO; Oumar Coulibaly S; Rakoto Alson AO; Soumana H; Tagny-Tayou C; Murphy EL; Laperche S;
    Transfusion; 2020 Jan; 60(1):106-116. PubMed ID: 31777096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.
    Grabarczyk P; Kubicka-Russel D; Kopacz A; Liszewski G; Sulkowska E; Zwolińska P; Madaliński K; Marek M; Szabelewska M; Świątek E; Laskus T; Radkowski M
    J Med Virol; 2020 Mar; 92(3):339-347. PubMed ID: 31670401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center.
    Chiquete E; Sánchez LV; Becerra G; Quintero A; Maldonado M; Panduro A
    Ann Hepatol; 2005; 4(4):275-8. PubMed ID: 16432494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
    Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
    Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus.
    Zhang K; Wang L; Sun Y; Zhang R; Lin G; Xie J; Li J
    Transfus Med; 2014 Oct; 24(5):297-304. PubMed ID: 25262976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
    Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples.
    Laperche S; Nübling CM; Stramer SL; Brojer E; Grabarczyk P; Yoshizawa H; Kalibatas V; El Elkyabi M; Moftah F; Girault A; van Drimmelen H; Busch MP; Lelie N
    Transfusion; 2015 Oct; 55(10):2489-98. PubMed ID: 26013970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.